Skip to main content

Table 2 Determination of Erava MIC value in the S. aureus derivatives with the overexpression of the three candidate genes and tet(K) and their impact on PAPs

From: Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus

Vectors

Strains

Erava MIC (mg/L)

PAP

Parental isolates

Derivative isolatesa

pRS00550

SE7

0.25

0.125

+

CHS545

0.125

0.125

+

CHS569

0.125

0.125

+

pRS01625

SE4

0.125

0.125

+

SE7

0.125

0.125

+

SE13

0.125

0.125

+

CHS545

0.125

0.125

+

CHS569

0.0625

0.125

+

pRS03535

SE13

0.125

0.125

–

CHS545

0.125

0.125

–

ptetK

SE7

0.125

0.125

–

SE13

0.125

0.0625

–

CHS545

0.25

0.125

–

CHS569

0.125

0.125

–

  1. PAP population analysis profiling
  2. a: The overexpression of USA300HOU_RS03535, USA300HOU_ RS01625, USA300HOU_RS00550 and tet(K) in S. aureus clinical isolates SE4, SE7, SE13, CHS545 and CHS569